4974.T
TAKARA BIO INC.
プライム · 化学 · 素材・化学 · JP
JPY 1,144.00
+0.09%Year over year
Reported trailing growth
- Revenue
- -10.5%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- -38.7%
Forward estimates
Based on analyst estimates
- Revenue
- +4.4%
- EBITDA
- —
- EPS
- +6.2%
Three-year CAGR
- Revenue
- -19.8%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026